ロード中...
A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressants
The severity of symptoms as well as efficacy of antidepressants in major depressive disorder (MDD) is modified by single nucleotide polymorphisms (SNPs) in different genes, which may contribute in an additive or synergistic fashion. We aimed to investigate depression severity in participants with MD...
保存先:
| 出版年: | Drug Dev Res |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7028038/ https://ncbi.nlm.nih.gov/pubmed/31617956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ddr.21609 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|